These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7616227)

  • 1. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.
    Loeffler DA; Connor JR; Juneau PL; Snyder BS; Kanaley L; DeMaggio AJ; Nguyen H; Brickman CM; LeWitt PA
    J Neurochem; 1995 Aug; 65(2):710-24. PubMed ID: 7616227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease.
    Griffiths PD; Crossman AR
    Dementia; 1993; 4(2):61-5. PubMed ID: 8358514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered systemic iron metabolism in Parkinson's disease.
    Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
    Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains.
    Connor JR; Snyder BS; Arosio P; Loeffler DA; LeWitt P
    J Neurochem; 1995 Aug; 65(2):717-24. PubMed ID: 7616228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
    Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
    J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases.
    Bartzokis G; Tishler TA; Shin IS; Lu PH; Cummings JL
    Ann N Y Acad Sci; 2004 Mar; 1012():224-36. PubMed ID: 15105269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases.
    Clevens RA; Beal MF
    Brain Res; 1989 May; 486(2):387-90. PubMed ID: 2471578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.
    Ge J; Barnes NM
    Eur J Pharmacol; 1996 Feb; 297(3):299-306. PubMed ID: 8666063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.
    Connor JR; Snyder BS; Beard JL; Fine RE; Mufson EJ
    J Neurosci Res; 1992 Feb; 31(2):327-35. PubMed ID: 1573683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
    Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.
    Lu LN; Qian ZM; Wu KC; Yung WH; Ke Y
    Mol Neurobiol; 2017 Sep; 54(7):5213-5224. PubMed ID: 27578012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes.
    Beal MF; Mazurek MF; Martin JB
    Brain Res; 1986 Nov; 397(2):386-8. PubMed ID: 3801878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
    Faucheux BA; Herrero MT; Villares J; Levy R; Javoy-Agid F; Obeso JA; Hauw JJ; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 691(1-2):115-24. PubMed ID: 8590043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians.
    Zambenedetti P; De Bellis G; Biunno I; Musicco M; Zatta P
    J Alzheimers Dis; 2003 Dec; 5(6):423-7. PubMed ID: 14757931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.